Attached files
| file | filename |
|---|---|
| 8-K - CURRENT REPORT - EUROPE 2001 HOLDRS TRUST | ss120463_8k-europe.htm |
|
PROSPECTUS SUPPLEMENT
|
EXHIBIT 99.1
|
|
(To Prospectus dated March 15, 2011)
|
REGISTRATION NO. 333-44286
|
1,000,000,000 Depositary Receipts
Europe 2001 HOLDRS (SM) Trust
This prospectus supplement supplements information contained in the prospectus dated March 15, 2011 relating to the sale of up to 1,000,000,000 depositary receipts by the Europe 2001 HOLDRS (SM) Trust.
The share amounts specified in the table in the “Highlights of Europe 2001 HOLDRS” section of the base prospectus shall be replaced with the following:
|
Name of Company(1)
|
Ticker
|
Share
Amounts |
Primary U.S.
Trading Market |
|||
|
AEGON N.V.
|
AEG
|
5.2000
|
NYSE
|
|||
|
Alcatel-Lucent*
|
ALU
|
3.0000
|
NYSE
|
|||
|
Amdocs Limited
|
DOX
|
3.0000
|
NYSE
|
|||
|
ARM Holdings, plc*
|
ARMH
|
8.0000
|
NASDAQ GS
|
|||
|
ASM International N.V.
|
ASMI
|
13.0000
|
NASDAQ GS
|
|||
|
ASML Holding N.V.
|
ASML
|
6.2222
|
NASDAQ GS
|
|||
|
AstraZeneca PLC.*
|
AZN
|
4.0000
|
NYSE
|
|||
|
BP p.l.c.*
|
BP
|
4.0000
|
NYSE
|
|||
|
Diageo p.l.c.*
|
DEO
|
5.0000
|
NYSE
|
|||
|
Elan Corporation, p.l.c.*
|
ELN
|
4.0000
|
NYSE
|
|||
|
LM Ericsson Telephone Company*
|
ERIC
|
3.2000
|
NASDAQ GS
|
|||
|
GlaxoSmithKline p.l.c.*
|
GSK
|
6.0000
|
NYSE
|
|||
|
ING Groep N.V.*
|
ING
|
4.0000
|
NYSE
|
|||
|
Koninklijke Philips Electronics N.V.
|
PHG
|
5.0000
|
NYSE
|
|||
|
Nokia Corporation*
|
NOK
|
5.0000
|
NYSE
|
|||
|
Novartis AG*
|
NVS
|
5.0000
|
NYSE
|
|||
|
Oclaro Inc.
|
OCLR
|
0.2400
|
NASDAQ GM
|
|||
|
Qiagen N.V.
|
QGEN
|
6.0000
|
NASDAQ GS
|
|||
|
Repsol YPF, S.A.*
|
REP
|
11.0000
|
NYSE
|
|||
|
Ryanair Holdings p.l.c.*
|
RYAAY
|
16.0000
|
NASDAQ GS
|
|||
|
Sanofi-Aventis SA*
|
SNY
|
4.6956
|
NYSE
|
|||
|
SAP AG*
|
SAP
|
4.0000
|
NYSE
|
|||
|
Shire plc*
|
SHPGY
|
4.0000
|
NASDAQ GS
|
|||
|
STMicroelectronics N.V.
|
STM
|
4.0000
|
NYSE
|
|||
|
Telefonica S.A.*
|
TEF
|
4.5558
|
NYSE
|
|||
|
Total S.A.*
|
TOT
|
6.0000
|
NYSE
|
|||
|
UBS AG
|
UBS
|
6.3000
|
NYSE
|
|||
|
Unilever N.V.
|
UN
|
9.0000
|
NYSE
|
|||
|
Vodafone Group Public Limited Company*
|
VOD
|
5.2500
|
NASDAQ GS
|
|||
|
WPP Group plc
|
WPPGY
|
3.0000
|
NASDAQ GS
|
___________________________
* The securities of these non-U.S. companies trade in the United States as American Depository Receipts. Please see “Risk Factors” and “U.S. Federal Income Tax Consequences—Special considerations with respect to underlying securities of foreign issuers” for additional information relating to an investment in a non-U.S. company.
(1) Effective May 31, 2011 (the “delisting date”), Millicom International Cellular S.A., an underlying constituent of the Europe 2001 HOLDRS Trust (the “Trust”), was delisted from trading on NASDAQ GS. Pursuant to the prospectus for the Trust, if Millicom International Cellular S.A. is not listed for trading on another national
securities exchange within five business days from the delisting date, it shall be distributed by The Bank of New York Mellon. The rate of distribution is 0.08 Millicom International Cellular S.A. shares per Europe 2001 HOLDRS. The record date and pay date for the distribution shall be June 13, 2011 and June 16, 2011, respectively.
The share amounts listed in the table above reflect all previous stock splits, dividends and business combination transactions.
The date of this prospectus supplement is June 6, 2011.